380 related articles for article (PubMed ID: 22164924)
61. Yield of routine molecular analyses in colorectal cancer patients ≤70 years to detect underlying Lynch syndrome.
van Lier MG; Leenen CH; Wagner A; Ramsoekh D; Dubbink HJ; van den Ouweland AM; Westenend PJ; de Graaf EJ; Wolters LM; Vrijland WW; Kuipers EJ; van Leerdam ME; Steyerberg EW; Dinjens WN;
J Pathol; 2012 Apr; 226(5):764-74. PubMed ID: 22081473
[TBL] [Abstract][Full Text] [Related]
62. [Identification and management of HNPCC syndrome (hereditary non polyposis colon cancer), hereditary predisposition to colorectal and endometrial adenocarcinomas].
Olschwang S; Bonaïti C; Feingold J; Frébourg T; Grandjouan S; Lasset C; Laurent-Puig P; Lecuru F; Millat B; Sobol H; Thomas G; Eisinger F
Bull Cancer; 2004 Apr; 91(4):303-15. PubMed ID: 15242312
[TBL] [Abstract][Full Text] [Related]
63. An Ashkenazi founder mutation in the MSH6 gene leading to HNPCC.
Goldberg Y; Porat RM; Kedar I; Shochat C; Galinsky D; Hamburger T; Hubert A; Strul H; Kariiv R; Ben-Avi L; Savion M; Pikarsky E; Abeliovich D; Bercovich D; Lerer I; Peretz T
Fam Cancer; 2010 Jun; 9(2):141-50. PubMed ID: 19851887
[TBL] [Abstract][Full Text] [Related]
64. Clinical and Molecular Characterization of Brazilian Patients Suspected to Have Lynch Syndrome.
Carneiro da Silva F; Ferreira JR; Torrezan GT; Figueiredo MC; Santos ÉM; Nakagawa WT; Brianese RC; Petrolini de Oliveira L; Begnani MD; Aguiar-Junior S; Rossi BM; Ferreira Fde O; Carraro DM
PLoS One; 2015; 10(10):e0139753. PubMed ID: 26437257
[TBL] [Abstract][Full Text] [Related]
65. Population-based detection of Lynch syndrome in young colorectal cancer patients using microsatellite instability as the initial test.
Schofield L; Watson N; Grieu F; Li WQ; Zeps N; Harvey J; Stewart C; Abdo M; Goldblatt J; Iacopetta B
Int J Cancer; 2009 Mar; 124(5):1097-102. PubMed ID: 19072991
[TBL] [Abstract][Full Text] [Related]
66. Genetic mutation risk calculation in Lynch syndrome inheritance: Evaluating the utility of the PREMM
Aissaoui S; Cartellier C; Seytier T; Giraud S; Calender A
Bull Cancer; 2017 Mar; 104(3):288-294. PubMed ID: 28038733
[TBL] [Abstract][Full Text] [Related]
67. Evaluation of predictive models in daily practice for the identification of patients with Lynch syndrome.
Tresallet C; Brouquet A; Julié C; Beauchet A; Vallot C; Ménégaux F; Mitry E; Radvanyi F; Malafosse R; Rougier P; Nordlinger B; Laurent-Puig P; Boileau C; Emile JF; Muti C; Penna C; Hofmann-Radvanyi H
Int J Cancer; 2012 Mar; 130(6):1367-77. PubMed ID: 21520036
[TBL] [Abstract][Full Text] [Related]
68. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
[TBL] [Abstract][Full Text] [Related]
69. Review: Clinical aspects of hereditary DNA Mismatch repair gene mutations.
Sijmons RH; Hofstra RMW
DNA Repair (Amst); 2016 Feb; 38():155-162. PubMed ID: 26746812
[TBL] [Abstract][Full Text] [Related]
70. Next Generation Sequencing Reveals Novel Mutations in Mismatch Repair Genes and Other Cancer Predisposition Genes in Asian Patients with Suspected Lynch Syndrome.
Ow SGW; Tan KT; Yang H; Yap HL; Sapari NSB; Ong PY; Soong R; Lee SC
Clin Colorectal Cancer; 2019 Dec; 18(4):e324-e334. PubMed ID: 31350202
[TBL] [Abstract][Full Text] [Related]
71. Comparison of universal screening in major lynch-associated tumors: a systematic review of literature.
Kunnackal John G; Das Villgran V; Caufield-Noll C; Giardiello FM
Fam Cancer; 2022 Jan; 21(1):57-67. PubMed ID: 33426601
[TBL] [Abstract][Full Text] [Related]
72. Current clinical criteria for Lynch syndrome are not sensitive enough to identify MSH6 mutation carriers.
Sjursen W; Haukanes BI; Grindedal EM; Aarset H; Stormorken A; Engebretsen LF; Jonsrud C; Bjørnevoll I; Andresen PA; Ariansen S; Lavik LA; Gilde B; Bowitz-Lothe IM; Maehle L; Møller P
J Med Genet; 2010 Sep; 47(9):579-85. PubMed ID: 20587412
[TBL] [Abstract][Full Text] [Related]
73. Next Generation Sequencing in Molecular Diagnosis of Lynch Syndrome - a Pilot Study Using New Stratification Criteria.
Kašubová I; Holubeková V; Janíková K; Váňová B; Sňahničanová Z; Kalman M; Plank L; Lasabová Z
Acta Medica (Hradec Kralove); 2018; 61(3):98-102. PubMed ID: 30543514
[TBL] [Abstract][Full Text] [Related]
74. Screening for Lynch Syndrome in Cases with Colorectal Carcinoma from Mashhad.
Goshayeshi L; Khooiee A; Ghaffarzadegan K; Rahmani Khorram M; Bishehsari F; Hoseini B; Akhavan Rezayat K; Esmaeilzadeh A; Mosannen Mozaffari H; Ghanayee O; Lari S; Bahari A; Allahyari A; Bari A; Ganji A; Goshayeshi L; Rajabzadeh F; Esmaeili J
Arch Iran Med; 2017 Jun; 20(6):332-337. PubMed ID: 28646840
[TBL] [Abstract][Full Text] [Related]
75. Hereditary cancer registries improve the care of patients with a genetic predisposition to cancer: contributions from the Dutch Lynch syndrome registry.
Vasen HF; Velthuizen ME; Kleibeuker JH; Menko FH; Nagengast FM; Cats A; van der Meulen-de Jong AE; Breuning MH; Roukema AJ; van Leeuwen-Cornelisse I; de Vos Tot Nederveen Cappel WH; Wijnen JT
Fam Cancer; 2016 Jul; 15(3):429-35. PubMed ID: 26973060
[TBL] [Abstract][Full Text] [Related]
76. Genetic anticipation in Swedish Lynch syndrome families.
von Salomé J; Boonstra PS; Karimi M; Silander G; Stenmark-Askmalm M; Gebre-Medhin S; Aravidis C; Nilbert M; Lindblom A; Lagerstedt-Robinson K
PLoS Genet; 2017 Oct; 13(10):e1007012. PubMed ID: 29088233
[TBL] [Abstract][Full Text] [Related]
77. Recommendations to improve identification of hereditary and familial colorectal cancer in Europe.
Vasen HF; Möslein G; Alonso A; Aretz S; Bernstein I; Bertario L; Blanco I; Bulow S; Burn J; Capella G; Colas C; Engel C; Frayling I; Rahner N; Hes FJ; Hodgson S; Mecklin JP; Møller P; Myrhøj T; Nagengast FM; Parc Y; Ponz de Leon M; Renkonen-Sinisalo L; Sampson JR; Stormorken A; Tejpar S; Thomas HJ; Wijnen J; Lubinski J; Järvinen H; Claes E; Heinimann K; Karagiannis JA; Lindblom A; Dove-Edwin I; Müller H
Fam Cancer; 2010 Jun; 9(2):109-15. PubMed ID: 19763885
[TBL] [Abstract][Full Text] [Related]
78. [Identification and management of patients with Lynch syndrome].
Coffin E; Dhooge M; Abou Ali E; Dermine S; Lavole J; Palmieri LJ; Chaussade S; Coriat R
Presse Med; 2019 Sep; 48(9):904-914. PubMed ID: 31561847
[TBL] [Abstract][Full Text] [Related]
79. A frameshift mutation in exon 19 of MLH1 in a Chinese Lynch syndrome family: a pedigree study.
Sui QQ; Jiang W; Wu XD; Ling YH; Pan ZZ; Ding PR
J Zhejiang Univ Sci B; 2019 Jan.; 20(1):105-108. PubMed ID: 30614234
[TBL] [Abstract][Full Text] [Related]
80. Critical issues in the identification and management of patients with hereditary non-polyposis colorectal cancer.
Lackner C; Hoefler G
Eur J Gastroenterol Hepatol; 2005 Mar; 17(3):317-22. PubMed ID: 15716656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
